NCT05326750 · RECRUITING

Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases

This trial tests whether a gentle, non-invasive brain stimulation device, applied to the scalp over the back of the brain at 40 Hz, can improve symptoms in people who already have a neurodegenerative condition. Real stimulation is compared with sham stimulation. It is not a drug phase trial, so there is no phase stage, and nothing is proven or approved.

You may qualify if

  • Mild Cognitive Impairment due to Alzheimer's disease
  • Dementia with Lewy Bodies
  • Frontotemporal dementia
  • Idiopathic normal pressure hydrocephalus (iNPH)

You're excluded if

  • History of seizures
  • Pregnancy
  • Metal implants in the head (except dental fillings)
  • Electronic implants (i.e. pace-maker, implanted medical pump)
  • Age \<18 years

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-10-02

View full record on ClinicalTrials.gov

All APOE4 clinical trials